# EDGAR Filing Document

**Accession Number:** 0001419051
**File Stem:** 0000000000-23-001224
**Filing Date:** 2023-2
**Character Count:** 5779
**Document Hash:** 0d04225bdd1633a876bc59e0be5618c7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-23-001224.hdr.sgml**: 20230316

**ACCESSION NUMBER**: 0000000000-23-001224

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230206

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
- **CENTRAL INDEX KEY:** 0001419051
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **IRS NUMBER:** 451226465
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD

**BUSINESS ADDRESS:**
- **STREET 1:** 701 WILD ROSE LANE
- **CITY:** ELK CITY
- **STATE:** ID
- **ZIP:** 83525
- **BUSINESS PHONE:** (760) 295-7208

**MAIL ADDRESS:**
- **STREET 1:** 701 WILD ROSE LANE
- **CITY:** ELK CITY
- **STATE:** ID
- **ZIP:** 83525

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Friendly Auto Dealers, Inc.
- **DATE OF NAME CHANGE:** 20071120

## Text-Extract

```

United States securities and exchange commission logo

                             February 6, 2023

       Timothy G. Dixon
       President and Chief Executive Officer
       Therapeutic Solutions International, Inc.
       701 Wild Rose Lane
       Elk City, Idaho 83525

                                                        Re: Therapeutic
Solutions International, Inc.
                                                            Amendment No. 3 to
Registration Statement on Form S-1
                                                            Filed January 31,
2023
                                                            File No. 333-268070

       Dear Timothy G. Dixon:

              We have reviewed your amended registration statement and have the
following
       comment. In our comment, we may ask you to provide us with information
so we may better
       understand your disclosure.

              Please respond to this letter by amending your registration
statement and providing the
       requested information. If you do not believe our comment applies to your
facts and
       circumstances or do not believe an amendment is appropriate, please tell
us why in your
       response.

              After reviewing any amendment to your registration statement and
the information you
       provide in response to these comments, we may have additional comments.
Unless we note
       otherwise, our references to prior comments are to comments in our
January 27, 2023 letter.

       Amendment No. 3 to Form S-1 filed January 31, 2023

       Executive Compensation, page 46

   1.                                                   We note your revisions
in response to our prior comment 2. Please ensure that Footnotes 1
                                                        and 2 of your table
consistently apply to the years they reference. For example, it appears
                                                        that Footnote 1, which
is next to Timothy G. Dixon's 2022 salary figure, refers to
                                                        compensation that was
accrued and paid in 2021.
 Timothy G. Dixon
FirstName
TherapeuticLastNameTimothy    G. Dixon
            Solutions International, Inc.
Comapany6,NameTherapeutic
February    2023             Solutions International, Inc.
February
Page 2 6, 2023 Page 2
FirstName LastName
      Please contact Jordan Nimitz at 202-551-5831 or Margaret Schwartz at
202-551-
7153 with any questions.

                                                             Sincerely,

                                                             Division of
Corporation Finance
                                                             Office of
Industrial Applications and
                                                             Services
cc:      Hugh Kelso, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

![img-0.jpeg](img-0.jpeg)

CORPORATION FINANCE

# UNITED STATES  
SECURITIES AND EXCHANGE COMMISSION  
WASHINGTON, D.C. 20549

February 6, 2023

Timothy G. Dixon  
President and Chief Executive Officer  
Therapeutic Solutions International, Inc.  
701 Wild Rose Lane  
Elk City, Idaho 83525

# **Re: Therapeutic Solutions International, Inc.**  
**Amendment No. 3 to Registration Statement on Form S-1**  
**Filed January 31, 2023**  
**File No. 333-268070**

Dear Timothy G. Dixon:

We have reviewed your amended registration statement and have the following comment. In our comment, we may ask you to provide us with information so we may better understand your disclosure.

Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response.

After reviewing any amendment to your registration statement and the information you provide in response to these comments, we may have additional comments. Unless we note otherwise, our references to prior comments are to comments in our January 27, 2023 letter.

Amendment No. 3 to Form S-1 filed January 31, 2023

Executive Compensation, page 46

1. We note your revisions in response to our prior comment 2. Please ensure that Footnotes 1 and 2 of your table consistently apply to the years they reference. For example, it appears that Footnote 1, which is next to Timothy G. Dixon's 2022 salary figure, refers to compensation that was accrued and paid in 2021.

Timothy G. Dixon
Therapeutic Solutions International, Inc.
February 6, 2023
Page 2

Please contact Jordan Nimitz at 202-551-5831 or Margaret Schwartz at 202-551-7153 with any questions.

Sincerely,

Division of Corporation Finance
Office of Industrial Applications and
Services

cc: Hugh Kelso, Esq.